Browse the corpus

REFERENCES Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children , 5th ed, Philadelphia, PA: American College of Physicians, 2007, 97. Carver JR, Shapiro CL, Ng A, et al, “American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects,” J Clin Oncol , 2007, 25(25):3991-4008. [PubMed 17577017 ] Cushing B, Giller R, Cullen JW, et al, "Randomized Comparison of Combination Chemotherapy With Etoposide, Bleomycin, and Either High-Dose or Standard-Dose Cisplatin in Children and Adolescents With High-Risk Malignant Germ Cell Tumors: A Pediatric Intergroup Study − Pediatric Oncology Group 9049 and Children's Cancer Group 8882," J Clin Oncol , 2004, 22(13):2691-700. [PubMed 15226336 ] Dann EJ, Bar-Shalom R, Tamir A, et al, "Risk-Adapted BEACOPP Regimen Can Reduce the Cumulative Dose of Chemotherapy for Standard and High-Risk Hodgkin Lymphoma With No Impairment of Outcome," Blood , 2007, 109(3):905-9. [PubMed 17018856 ] Diehl V, Franklin J, Pfreundschuh M, et al, "Standard and Increased-Dose BEACOPP Chemotherapy Compared With COPP-ABVD for Advanced Hodgkin's Disease," N Engl J Med , 2003, 348(24):2386-95. [PubMed 12802024 ] Engert A, Franklin J, Eich HT, et al, "Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial," J Clin Oncol , 2007, 25(23):3495-502. [PubMed 17606976 ] Griggs JJ, Mangu PB, Anderson H, et al, “Appropriate Chemotherapy Dosing For Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline,” J Clin Oncol , 2012, 30(13):1553-61. [PubMed 22473167 ] Horning SJ, Hoppe RT, Breslin S, et al, "Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin's Disease: Mature Results of a Prospective Clinical Trial," J Clin Oncol , 2002, 20(3):630-7. [PubMed 11821442 ] Horning SJ, Williams J, Bartlett NL, et al, "Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin's Disease: Eastern Cooperative Oncology Group Pilot Study E1492," J Clin Oncol , 2000, 18(5):972-80. [PubMed 10694546 ]

Horning SJ, Hoppe RT, Breslin S, et al, "Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin's Disease: Mature Results of a Prospective Clinical Trial," J Clin Oncol , 2002, 20(3):630-7. [PubMed 11821442 ] Horning SJ, Williams J, Bartlett NL, et al, "Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin's Disease: Eastern Cooperative Oncology Group Pilot Study E1492," J Clin Oncol , 2000, 18(5):972-80. [PubMed 10694546 ] Hoskin PJ, Lowry L, Horwich A, et al, "Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244," J Clin Oncol , 2009, 27(32):5390-6. [PubMed 19738111 ] Huang TT, Hudson MM, Stokes DC, et al, “Pulmonary Outcomes in Survivors of Childhood Cancer: A Systematic Review,” Chest , 2011, 140(4): 881-901. [PubMed 21415131 ] Hutchinson RJ, Fryer CJ, Davis PC, et al, "MOPP or Radiation in Addition to ABVD in the Treatment of Pathologically Staged Advanced Hodgkin's Disease in Children: Results of the Children's Cancer Group Phase III Trial," J Clin Oncol , 1998, 16(3):897-906. [PubMed 9508171 ] Ibrahimi OA and Anderson RR, "Images in Clinical Medicine. Bleomycin-Induced Flagellate Hyperpigmentation," N Engl J Med , 2010, 363(24):e36. [PubMed 21142531 ] Johnson PW, Radford JA, Cullen MH, et al, "Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin's Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)," J Clin Oncol , 2005, 23(36):9208-18. [PubMed 16314615 ] King PD and Perry MC, “Hepatotoxicity of Chemotherapy,” Oncologist , 2001, 6(2):162-76. [PubMed 11306728 ] Kintzel PE and Dorr RT, "Anticancer Drug Renal Toxicity and Elimination: Dosing Guidelines for Altered Renal Function," Cancer Treat Rev , 1995, 21(1):33-64. [PubMed 7859226 ] Kung FH, Schwartz CL, Ferree CR, et al, "POG 8625: A Randomized Trial Comparing Chemotherapy With Chemoradiotherapy for Children and Adolescents With Stages I, IIA, IIIA1 Hodgkin Disease: A Report From the Children's Oncology Group," J Pediatr Hematol Oncol , 2006, 28(6):362-8. [PubMed 16794504 ] Lam MS, "The Need for Routine Bleomycin Test Dosing in the 21st Century," Ann Pharmacother , 2005, 39(11):1897-902. [PubMed 16219896 ]

Kung FH, Schwartz CL, Ferree CR, et al, "POG 8625: A Randomized Trial Comparing Chemotherapy With Chemoradiotherapy for Children and Adolescents With Stages I, IIA, IIIA1 Hodgkin Disease: A Report From the Children's Oncology Group," J Pediatr Hematol Oncol , 2006, 28(6):362-8. [PubMed 16794504 ] Lam MS, "The Need for Routine Bleomycin Test Dosing in the 21st Century," Ann Pharmacother , 2005, 39(11):1897-902. [PubMed 16219896 ] National Comprehensive Cancer Network® (NCCN), "Clinical Practice Guidelines in Oncology™: Head and Neck Cancers," Version 1.2011. Available at file://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf National Institute for Occupational Safety and Health (NIOSH), "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012." Available at file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf . Accessed January 21, 2013. Straus DJ, Portlock CS, Qin J, et al, "Results of a Prospective Randomized Clinical Trial of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Followed by Radiation Therapy (RT) Versus ABVD Alone for Stages I, II, and IIIA Nonbulky Hodgkin Disease," Blood , 2004, 104(12):3483-9. [PubMed 15315964 ] Topic 13088 Version 36.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1004-183.166.191.243-DB525E7F52-S244013.14]